Twice-weekly dosing: the smooth wave Split dosing compresses the cycle
Tumor sidedness and efficacy of first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer: a network meta-analysis
In the pivotal SURPASS trials evaluating tirzepatide for type 2 diabetes, nausea occurred in 1222% of patients depending on the dose (5 mg, 10 mg, or 15 mg weekly), compared to approximately 58% with placebo
To get started, simply request an appointment
A gold carding feature is expected by mid-2026 to exempt providers with high approval histories
DMF mediates NRF2-dependent and independent mechanisms on TSS pathway CBS activation DMF activates NRF2, the master regulator for the antioxidative stress response, to regulate the expression of proteins involved in iron hemostasis, and GSH synthesis such as HMOX1, NQO1, FTH, FTL, SLC40A1 in a variety of cellular systems 37